Correlation analysis between of sequelae COVID-19 and fingertip blood NAD+ level

Correlation analysis between sequelae of COVID-19 and fingertip blood NAD+ level

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2300072077

Enrollment

Unknown

Registered

2023-06-01

Start date

2023-06-02

Completion date

Unknown

Last updated

2023-06-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sequelae of COVID-19

Interventions

Healthy group:N/A

COVID-19 sequelae population group:N/A

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) Patients who have been diagnosed with COVID-19 and have tested positive for nucleic acid. Other persistent symptoms may include poor breathing, weakness, joint pain, palpitation, myalgia, smell and taste dysfunction, cough, headache, gastrointestinal problems, cognitive and psychiatric disorders, etc. (2) Age range from 18 to 80 years old; (3) non-pregnant and lactating women; (4) Willing and have the time to participate in the study.

Exclusion criteria

Exclusion criteria: (1) Patients with severe acute and chronic diseases (accompanied by serious complications, liver and kidney dysfunction, infectious diseases, heart dysfunction, etc.); (2) Patients who cannot take care of themselves or have mental illness. (3) faint blood, faint needle

Design outcomes

Primary

Measure	Time frame
Fingertip blood NAD+ level;	—

Secondary

Measure	Time frame
Gender, age, height, weight;	—

Countries

China

Contacts

Public ContactQiuLiyang Yu

Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences

q.yu@siat.ac.cn+86 136 9172 1365

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026